ProfileGDS5678 / 1455963_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% 3% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 11.966853
GSM967853U87-EV human glioblastoma xenograft - Control 21.948523
GSM967854U87-EV human glioblastoma xenograft - Control 31.950183
GSM967855U87-EV human glioblastoma xenograft - Control 41.90433
GSM967856U87-EV human glioblastoma xenograft - Control 51.897443
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 11.987553
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 21.974253
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 31.927223
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 41.920593
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 11.939173
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 21.935313
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 31.92333
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 41.936323
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 51.939693